Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000771856-25-000023
Filing Date
2025-09-15
Accepted
2025-09-15 16:50:25
Documents
62
Period of Report
2025-07-31

Document Format Files

Seq Description Document Type Size
1 10-Q csbr-20250731.htm   iXBRL 10-Q 734905
2 EX-31.1 csbrq1731202510-qex311.htm EX-31.1 10596
3 EX-31.2 csbrq1731202510-qex312.htm EX-31.2 10699
4 EX-32.1 csbrq1731202510-qex321.htm EX-32.1 7762
  Complete submission text file 0000771856-25-000023.txt   5018502

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20250731.xsd EX-101.SCH 35504
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT csbr-20250731_cal.xml EX-101.CAL 56247
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20250731_def.xml EX-101.DEF 145082
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20250731_lab.xml EX-101.LAB 517545
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20250731_pre.xml EX-101.PRE 341838
65 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20250731_htm.xml XML 658074
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-11504 | Film No.: 251314863
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)